Four decades of therapy for AML

Leukemia

Volumn 12, Issue SUPPL. 1, 1998, Pages

  Freireich, Emil J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CYTOGENETICS; HUMAN; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

EID: 0031785014     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Farber S, Appleton R, Downing FH, King J, Toch R. The treatment of acute leukemia in children by folic acid antagonists, ACTH, and cortisone. A summary of five years of experience. Proceedings of the Fourth International Congress of the International Society of Hematology. New York, Grune and Stratton, 1954 p. 150.
2. Haut A, Altman SJ, Cartwright GE, Wintrobe MM. The influence of chemotherapy on survival in acute leukemia. Blood 1955;10:875-894.
3. Kliman A, Gaydos LA, Schroeder LR, Freireich EJ. Repeated plasmapheresis of blood donors as a source of platelets. From the Division of Biologics Standards and the National Cancer Institute, National Institutes of Health, Bethesda, Md.
4. Dameshek W, Necheles TF, Finkel HE, Allen AM. Therapy of Acute Leukemia, 1965. Blood 1965;26:220-224.
5. Rodriguez V, Hart JS, Freireich EJ, et al. POMP combination chemotherapy of adult acute leukemia. Cancer 1973;32:69-75.
6. Frei E III, Bickers JN, Hewlett JS, Lane M, Leary WV, Talley RW. Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). Cancer Res 1969;29:1325-1332.
7. Southwest Oncology Group. Cytarabine for acute leukemia in adults: effect of schedule on therapeutic response. Leukemia Ther 1974;133:251-259.
8. Crosby WH. Grounds for optimism in treating acute granulocytic leukemia. Arch Intern Med 1974;134:177-180.
9. Freireich EJ, Cork A, Stass SA, et al. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia. Leukemia 1992;6:500-506.